Mutations in RNA‐dependent RNA polymerase could be major cause of high pandemic potential of SARS‐CoV‐2: An in‐silico study

https://doi.org/10.22146/ijbiotech.104453

Bhawna Sharma(1), Bennet Angel(2*), Annette Angel(3), Vinod Joshi(4), Shareef Mohammed Buvvaji(5), Neha Singh(6), Khushbu Kumari(7), Aarya Chitransh(8), Poorna Khaneja(9), Devendra Kumar(10)

(1) Centre of Excellence in Virology & Immunology, Sharda University, Uttar Pradesh, India‐201310
(2) Centre of Excellence in Virology & Immunology, Sharda University, Uttar Pradesh, India‐201310
(3) Centre of Excellence in Virology & Immunology, Sharda University, Uttar Pradesh, India‐201310
(4) Centre of Excellence in Virology & Immunology, Sharda University, Uttar Pradesh, India‐201310
(5) Centre of Excellence in Virology & Immunology, Sharda University, Uttar Pradesh, India‐201310
(6) Centre of Excellence in Virology & Immunology, Sharda University, Uttar Pradesh, India‐201310
(7) Centre of Excellence in Virology & Immunology, Sharda University, Uttar Pradesh, India‐201310
(8) Centre of Excellence in Virology & Immunology, Sharda University, Uttar Pradesh, India‐201310
(9) Centre of Excellence in Virology & Immunology, Sharda University, Uttar Pradesh, India‐201310
(10) Department of Respiratory Medicine, Sharda School of Medical Sciences & Research, Sharda Hospital, Greater Noida, U.P., India‐201310
(*) Corresponding Author

Abstract


Human coronaviruses (HCoVs) are responsible for mild common cold to severe pneumonia‐like symptoms in infected individuals. The first HCoV was HCoV‐229E, discovered in 1962 in the US, which causes moderate symptoms. Since then, HCoVs have evolved, leading to epidemics or the recent SARS‐CoV‐2 pandemic. The main objective of this study was to understand the modifications occurred and what led to the transition from mild to pandemic form. Of the viral proteins, the RNA‐dependent RNA polymerase (RdRp) plays a crucial role in viral evolution, mutation, pathogenesis and transmission; this protein was therefore analyzed using in silico tools. We observed that RdRp has shown many mutations during its transition from mild to severe forms in HCoVs, which may have affected its enzymatic activity. The RdRp of HoV‐229E and HCoV‐NL63 showed 171 mutations, while SARS‐CoV‐2 showed the presence of 312. SARS‐CoV‐2 also showed a reduction in hydrophobic amino acid compared to the other HCoVs, consequently contributing to faster replication. Although mutations in the RdRp subdomains were found, yet five conserved regions was also presence among all the seven HCoVs; the finger and thumb subdomains had one conserved region, while the palm subdomains had three. Therefore, it can be inferred that on one hand the mutations reported in RdRp appeared to be the major cause of increased virulence leading to sporadic disease outbreaks, while on the other hand the presence of five conserved regions might prove to be potential targets for the development of new antiviral drugs.


Keywords


Evolution; Human coronaviruses; Mutations; NSP12; RdRp; SARS‐CoV‐2



References

Babicki S, Arndt D, Marcu A, Liang Y, Grant JR, Maciejewski A, Wishart DS. 2016. Heatmapper: webenabled heat mapping for all. Nucleic Acids Res. 44(1):W147–53. doi:10.1093/NAR/GKW419.

Braun T, Bordería AV, Barbezange C, Vignuzzi M, Louzoun Y. 2019. Long­Term contextdependent genetic adaptation of the viral genetic cloud. Bioinformatics 35(11):1907–1915. doi:10.1093/bioinformatics/bty891.

Burrell CJ, Howard CR, Murphy FA. 2016. Coronavirus ­ an overview | ScienceDirect Topics Chapter 31. Fenner White’s Med. Virol. p. 437–446.

Cicaloni V, Costanti F, Pasqui A, Bianchini M, Niccolai N, Bongini P. 2022. A Bioinformatics Approach to Investigate Structural and Non­Structural Proteins in Human Coronaviruses. Front. Genet. 13:891418. doi:10.3389/fgene.2022.891418.

Haagmans BL, Osterhaus ADME. 2009. SARS. Academic Press. p. 671–683. Hebditch M, Carballo­Amador MA, Charonis S, Curtis R, Warwicker J. 2017. Protein­Sol: A web tool for predicting protein solubility from sequence. Bioinformatics 33(19):3098–3100. doi:10.1093/bioinformatics/btx345.

Lamers MM, Haagmans BL. 2022. SARS­CoV­2 pathogenesis. Nat. Rev. Microbiol. 20(5):270–284. doi:10.1038/s41579­022­00713­0.

Lee H, Liu Y, Mejia E, Paul AV, Wimmer E. 2006. The CTerminal Hydrophobic Domain of Hepatitis C Virus RNA Polymerase NS5B Can Be Replaced with a Heterologous Domain of Poliovirus Protein 3A. J. Virol. 80(22):11343–11354. doi:10.1128/jvi.02072­05.

Liu DX, Liang JQ, Fung TS. 2021. Human Coronavirus­ 229E, ­OC43, ­NL63, and ­HKU1 (Coronaviridae). Ref. Mod. Life Sci. 1­5:428–440. doi:10.1016/B978­ 0­12­809633­8.21501­X.

Ludwig S, Zarbock A. 2020. Coronaviruses and SARSCoV­2: A Brief Overview. Anesth. Analg. 131(1):93– 96. doi:10.1213/ANE.0000000000004845.

Matyášek R, Řehůřková K, Marošiová KB, Kovařík A. 2021. Mutational asymmetries in the SARSCov­2 genome may lead to increased hydrophobicity of virus proteins. Genes (Basel). 12(6):826. doi:10.3390/genes12060826.

Miłek J, Blicharz­Domańska K. 2018. Coronaviruses in avian species­review with focus on epidemiology and diagnosis in wild birds. J. Vet. Res. 62(3):249. doi:10.2478/jvetres­2018­0035.

Nishimura Y, Yoshida T, Kuronishi M, Uehara H, Ogata H, Goto S. 2017. ViPTree: The viral proteomic tree server. Bioinformatics 33(15):2379– 2380. doi:10.1093/bioinformatics/btx157.

Protein Data Bank. 1971. Protein Data Bank. Sarma H, Jamir E, Sastry GN. 2022. Protein­protein interaction of RdRp with its co­factor NSP8 and NSP7 to decipher the interface hotspot residues for drug targeting: A comparison between SARS­CoV­ 2 and SARS­CoV. J. Mol. Struct. 1257:132602. doi:10.1016/j.molstruc.2022.132602.

Schrödinger L, DeLano W. 2020. PyMOL. URL http: //www.pymol.org/pymol.

Sharma B, Angel B, Naik VU, Angel A, Joshi V, Shareef B, Singh N, Khan AS, Khaneja P, Barthwal S, Joshi R, Peer NM, Yadav K, Tomar K, Singh SP. 2023. Repurposed drug molecules targeting NSP12 protein of SARS­CoV­2: An in­silico study. AIMS Mol. Sci. 10(4):322–342. doi:10.3934/molsci.2023019.

Smertina E, Urakova N, Strive T, Frese M. 2019. Calicivirus RNA­dependent RNA polymerases: Evolution, structure, protein dynamics, and function. Front. Microbiol. 10(JUN):1280. doi:10.3389/fmicb.2019.01280.

Tang G, Liu Z, Chen D. 2022. Human coronaviruses: Origin, host and receptor. J. Clin. Virol. 155:105246. doi:10.1016/j.jcv.2022.105246.

Venkataraman S, Prasad BV, Selvarajan R. 2018. RNA dependent RNA polymerases: Insights from structure, function and evolution. Viruses 10(2):76. doi:10.3390/v10020076.

Vicenti I, Zazzi M, Saladini F. 2021. SARS­CoV­2 RNAdependent RNA polymerase as a therapeutic target for COVID­19. Expert Opin. Ther. Pat. 31(4):325–337. doi:10.1080/13543776.2021.1880568.

Wang H, Pipes L, Nielsen R. 2020. Synonymous mutations and the molecular evolution of SARS­CoV­2 origins. Virus Evol. 7(1):veaa098. doi:10.1093/ve/veaa098.

Wei M, Yang N, Wang F, Zhao G, Gao H, Li Y. 2019. Epidemiology of Coronavirus Disease 2019 (COVID­19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS­CoV­2). Disaster Med. Public Health Prep. 14(6):796–804. doi:10.1017/dmp.2020.155.

Wolf YI, Kazlauskas D, Iranzo J, Lucía­Sanz A, Kuhn JH, Krupovic M, Dolja VV, Koonin EV. 2018. Origins and evolution of the global RNA virome. MBio 9(6):e02329–18. doi:10.1128/mBio.02329­18.

Wong NA, Saier MH. 2021. The SARS­coronavirus infection cycle: A survey of viral membrane proteins, their functional interactions and pathogenesis. Int. J. Mol. Sci. 22(3):1308. doi:10.3390/ijms22031308.

Zhao X, Ding Y, Du J, Fan Y. 2020. 2020 update on human coronaviruses: One health, one world. Med. Nov. Technol. Devices 8:100043. doi:10.1016/j.medntd.2020.100043.



DOI: https://doi.org/10.22146/ijbiotech.104453

Article Metrics

Abstract views : 4079 | views : 1231 | views : 955

Refbacks

  • There are currently no refbacks.


Copyright (c) 2025 The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.